Reproductive medicine and maternal health

people-families

Reproductive medicine & maternal health

Increasing numbers of couples are seeking help to conceive and Ferring is committed to supporting everyone from conception to birth.

Reproductive medicine & maternal health

Ferring is a world leader in Assisted Reproductive Technology (ART) for fertility treatment. Ferring’s on-going research efforts in this area strive to meet the growing needs of patients as increasing numbers of couples seek help to conceive. Ferring also offers a range of peptide-based medicines to prevent pre-term labour. Ferring has developed MENOPUR® (menotropin) to stimulate the ovaries, DECAPEPTYL®/GONAPEPTYL ® (gonadotropin releasing hormone agonist) to control the timing of ovary stimulation , CHORAGON® (human chorionic gonadatropin) to induce ovulation and ENDOMETRIN®/LUTINUS® ( progesterone vaginal tablet) for luteal phase support.

Research at Ferring into the use of oxytocin antagonists to help manage and prevent pre-term labour, led to the development of TRACTOCILE® (atosiban).

A novel peptide (barusiban) is in advance`d clinical trials to aid implantation support in ART.

Join the #projectfamily conversation

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.

OK

Cette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.

OK

Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals

OK

Ez az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.

OK

Ta strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.

OK

Эта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.

OK